aXichem
1.125 SEK -2.6%Be the first to follow this company
aXichem is active in industrial biotechnology. The company develops, patents and markets industrial chemicals. The company mainly works with Phenylcapsaicin, a natural analog synthetic capsaicin with applications in a variety of areas, such as in the marine sector, among pest control in forestry and agriculture, as well as among individual pharmaceutical work areas. Operations are run on a global level, with the head office in Malmö.
Revenue
1.81M
EBIT %
-956.91 %
P/E
-
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
First North Stockholm
AXIC A
Daily low / high price
1.065 / 1.195
SEK
Market cap
45.34M SEK
Turnover
89.57K SEK
Volume
81K
Financial calendar
Interim report
2024-05-23
General meeting
2024-06-19
Interim report
2024-08-27
Interim report
2024-11-28
Annual report
2025-02-27
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
LMK Forward | 12.2 % | 11.1 % |
Manakin Ltd | 9.1 % | 9.1 % |
Premium
This content is for our Premium customers only.
ShowingAll content types
aXichem AB: aXichem ser en fortsatt positiv trend för aXivite, bekräftad genom nya ordrar från Uriach och Pharmafoods
aXichem AB: aXichem meddelar sista dag för handel i BTU och första dag för handel i teckningsoptioner serie TO1A
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools